Showing results (411-420 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|March 7, 2020
Monoclonal antibodies in multiple myeloma: Current and emerging targets and mechanisms of actionKitsada Wudhikarn, Beatriz Wills, Alexander M LesokhinBest Practice & Research. Clinical Haematology|March 7, 2020
Reconstructing the evolutionary history of multiple myelomaFrancesco Maura, Even H Rustad, Eileen M Boyle, et al.Best Practice & Research. Clinical Haematology|March 7, 2020
Tracking myeloma tumor DNA in peripheral bloodJohannes M Waldschmidt, Tushara Vijaykumar, Birgit Knoechel, et al.Best Practice & Research. Clinical Haematology|March 7, 2020
Modern treatments and future directions for newly diagnosed multiple myeloma patientsSydney X LuBest Practice & Research. Clinical Haematology|November 30, 2019
Maintenance therapy after allogeneic hematopoietic cell transplantation for acute myeloid leukemiaFrederick R AppelbaumBest Practice & Research. Clinical Haematology|November 30, 2019
What is the role of the microenvironment in MDS?Laura M Calvi, Allison J Li, Michael W BeckerBest Practice & Research. Clinical Haematology|November 30, 2019
Can we selectively target AML stem cells?Craig T JordanBest Practice & Research. Clinical Haematology|November 30, 2019
What do functional genomics tell us about pathogenesis of AML?Jeffrey W Tyner, Daniel Bottomly, Beth Wilmot, et al.Best Practice & Research. Clinical Haematology|November 30, 2019
Is post-transplant cyclophosphamide a true game-changer in allogeneic transplantation: The struggle to unlearnRichard J JonesBest Practice & Research. Clinical Haematology|October 23, 2004
Natural killer cells as a therapeutic tool in mismatched transplantationLoredana Ruggeri, Marusca Capanni, Antonella Mancusi, et al.Pageof 113